These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8944331)

  • 41. Quality control requirements in estrogen receptor determination.
    Bojar H
    Cancer Res; 1986 Aug; 46(8 Suppl):4249s-4250s. PubMed ID: 3524806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.
    Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Christiaens MR; Vergote I
    Breast Cancer Res Treat; 2005 May; 91(1):81-7. PubMed ID: 15868434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology.
    Koenders PG; Faverly D; Beex LV; Bruggink ED; Kienhuis CB; Benraad TJ
    Eur J Cancer; 1992; 28(2-3):693-7. PubMed ID: 1591096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationships of steroid hormone receptors, age and histological characteristics in human breast cancer.
    Mureşan Z; Duţu R; Voiculetz N
    Neoplasma; 1986; 33(3):371-7. PubMed ID: 3016577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay.
    Krambovitis E; Hatzidakis G; Hatzoglou A; Romain S; Durand A; Stefanakis A; Castanas E
    Clin Chem; 1995 Jan; 41(1):48-53. PubMed ID: 7813080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
    Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
    Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program.
    Francis GD; Dimech M; Giles L; Hopkins A
    J Clin Pathol; 2007 Nov; 60(11):1277-83. PubMed ID: 17259294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chromatographic separation of eight progesterone receptor isoforms in human breast tumors, and detection by radioligand and monoclonal antibodies. Association with hsp90 and hsp70 heat shock proteins.
    Lemoisson E; Cren H; Goussard J
    Ann Biol Clin (Paris); 1994; 52(6):433-42. PubMed ID: 7856945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
    Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An enzyme immunoassay compared with a ligand-binding assay for measuring progesterone receptors in cytosols from breast cancers.
    Smyth CM; Benn DE; Reeve TS
    Clin Chem; 1988 Jun; 34(6):1116-8. PubMed ID: 3288376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols.
    Ryan ED; Clark AF; Mobbs BG; Ooi TC; Sutherland DJ; Tustanoff ER
    Clin Biochem; 1985 Feb; 18(1):20-6. PubMed ID: 3986988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Breast neoplasms: possible prognostic role of steroid receptors].
    Barbi GP; Marroni P; Zappa R; Bruzzi P; Nicolò G; Toma S; Paganuzzi M; Ferrara GB
    Minerva Ginecol; 1987 Apr; 39(4):225-8. PubMed ID: 3601195
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cancer of the breast and the receptor status].
    Buonomo O; Serao A; Muggianu A; Guglielmelli E; Davoli E; Amori A
    G Chir; 1991 Apr; 12(4):274-7. PubMed ID: 1911078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of steroid receptors in breast cancer: relationship between EIA and IHC methods.
    Lerma E; Esqué C; Peiró G; Mora J; Cerdá I; Prat J
    Scand J Clin Lab Invest; 1994 Dec; 54(8):591-4. PubMed ID: 7709160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effect of E2 and progesterone on the receptor status in endometrial carcinoma].
    Gorchev G; Milkov V; Tanchev S; Popov I
    Akush Ginekol (Sofiia); 1992; 31(2):27-8. PubMed ID: 1342552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
    Schenck U; Jütting U; Eiermann W
    Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
    Kiang DT; Kollander R
    J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estradiol and progesterone receptors in normal ovary and ovarian tumors.
    Lantta M
    Acta Obstet Gynecol Scand; 1984; 63(6):497-503. PubMed ID: 6507051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.
    Nicholson RI; Colin P; Francis AB; Keshra R; Finlay P; Williams M; Elston CW; Blamey RW; Griffiths K
    Cancer Res; 1986 Aug; 46(8 Suppl):4299s-4302s. PubMed ID: 3524811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.